Skopos Labs, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 45 shares of AMPH stock, worth $1,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$1,606% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
283Shares Held
34.8MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$212 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$96.8 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$76.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$69.5 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$57.7 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.75B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...